AR049210A1 - COMPOSITION WITH TENSIOACTIVE COMPOUNDS, FOR THE REDUCTION OF FAT LOCATED IN THE HUMAN BODY AND A METHOD FOR REDUCING SUCH FAT LOCALIZED - Google Patents
COMPOSITION WITH TENSIOACTIVE COMPOUNDS, FOR THE REDUCTION OF FAT LOCATED IN THE HUMAN BODY AND A METHOD FOR REDUCING SUCH FAT LOCALIZEDInfo
- Publication number
- AR049210A1 AR049210A1 ARP050102333A ARP050102333A AR049210A1 AR 049210 A1 AR049210 A1 AR 049210A1 AR P050102333 A ARP050102333 A AR P050102333A AR P050102333 A ARP050102333 A AR P050102333A AR 049210 A1 AR049210 A1 AR 049210A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- fat
- reduction
- human body
- composition according
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- 239000004094 surface-active agent Substances 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 208000004998 Abdominal Pain Diseases 0.000 abstract 1
- 208000002881 Colic Diseases 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- 239000004367 Lipase Substances 0.000 abstract 1
- 102000004882 Lipase Human genes 0.000 abstract 1
- 108090001060 Lipase Proteins 0.000 abstract 1
- 108090000526 Papain Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 150000002334 glycols Chemical class 0.000 abstract 1
- 235000019421 lipase Nutrition 0.000 abstract 1
- 230000002366 lipolytic effect Effects 0.000 abstract 1
- 229940055729 papain Drugs 0.000 abstract 1
- 235000019834 papain Nutrition 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000008180 pharmaceutical surfactant Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Composicion con compuestos tensioactivos, su uso para la reduccion de la grasa localizada en el cuerpo humano y un método para reducir la grasa localizada a través del contacto de dichos tensioactivos con el tejido celular subcutáneo. Reivindicacion 1: Una composicion para la reduccion de la grasa localizada, caracterizada por el hecho de que contiene una cantidad efectiva de uno o más compuestos tensioactivos farmacéuticamente aceptables, auxiliares y excipientes, segun sea necesario. Reivindicacion 7: Una composicion, de acuerdo con la reivindicacion 3, caracterizada por el hecho de que dicho compuesto tensoactivo es uno o más de los siguientes ácidos: colico, desoxicolico, taurocolico, taurodesoxicolico, tauroursodesoxicolico, tauroquenodesoxicolico, taurolitocolico, glicocolico, glicodesoxicolico, glicolitocolico, glicoquenodesoxicolico, quénico, quenodesoxicolico, ursocolico, ursodesoxicolico, isoursodesoxicolico, lagodesoxicolico, deshidrocolico, hiocolico, hiodesoxicolico, muricolico, litocolico o ácido sulfolitocolico, así como sus sales, isomeros y derivados. Reivindicacion 13: Una composicion, de acuerdo con la reivindicacion 12, caracterizada por el hecho de que contiene 0,3% a 1% en peso de un anetésico y/o de un agente preservativo, particularmente bencil alcohol. Reivindicacion 14: Una composicion, de acuerdo con la reivindicacion 12, caracterizada por el hecho de contener 5 a 10% en peso de un co-solvente, particularmente uno o más de los glicoles o de sorbitol. Reivindicacion 15: Una composicion, de acuerdo con cualquiera de las reivindicaciones 1 a 14, caracterizada por el hecho de que contiene agentes lipolíticos adicionales, particularmente la lipasa o la papaína.Composition with surfactant compounds, their use for the reduction of localized fat in the human body and a method to reduce localized fat through the contact of said surfactants with subcutaneous cellular tissue. Claim 1: A composition for localized fat reduction, characterized in that it contains an effective amount of one or more pharmaceutically acceptable surfactant compounds, auxiliaries and excipients, as necessary. Claim 7: A composition according to claim 3, characterized in that said surfactant compound is one or more of the following acids: colic, deoxycholic, taurocolic, taurodeoxycholic, tauroursodeoxycholic, tauroquenodeoxycholic, taurolitocolic, glycololic, glycololic, glycolic, , glycokenodeoxycholic, chemical, chenodeoxycholic, ursocolic, ursodeoxycholic, isoursodeoxycholic, lake deoxycholic, dehydrocolic, hyocolic, hyodeoxycholic, muricolic, lithocolic or sulfolitocolic acid, as well as their salts, isomers and derivatives. Claim 13: A composition according to claim 12, characterized in that it contains 0.3% to 1% by weight of an anesthetic and / or a preservative agent, particularly benzyl alcohol. Claim 14: A composition, according to claim 12, characterized in that it contains 5 to 10% by weight of a co-solvent, particularly one or more of the glycols or sorbitol. Claim 15: A composition according to any one of claims 1 to 14, characterized in that it contains additional lipolytic agents, particularly lipase or papain.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BR2004/000123 WO2006007675A1 (en) | 2004-07-20 | 2004-07-20 | Cholic acid and/or its derivatives for the reduction of localized fat in the human body |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049210A1 true AR049210A1 (en) | 2006-07-05 |
Family
ID=35784823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102333A AR049210A1 (en) | 2004-07-20 | 2005-06-08 | COMPOSITION WITH TENSIOACTIVE COMPOUNDS, FOR THE REDUCTION OF FAT LOCATED IN THE HUMAN BODY AND A METHOD FOR REDUCING SUCH FAT LOCALIZED |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR049210A1 (en) |
| BR (1) | BRPI0418963A (en) |
| WO (1) | WO2006007675A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2422789T1 (en) * | 2004-05-19 | 2018-07-31 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | An injectable composition comprising sodium deoxycholate |
| US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
| MX363465B (en) | 2011-02-18 | 2019-03-25 | Kythera Biopharmaceuticals Inc | Treatment of submental fat. |
| US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
| US9426242B2 (en) * | 2013-01-29 | 2016-08-23 | Apple Inc. | Determining an invitational content item type based on predicted user attention |
| KR102230271B1 (en) * | 2019-11-13 | 2021-03-19 | 이환석 | Injectable formulation and composition for reducing of fat comprising Glycodeoxycholic acid |
| JP2024535386A (en) * | 2022-07-05 | 2024-09-30 | グロノバ ファーマ シーオー．，エルティディー． | Injectable compositions comprising a cytolytic compound in a gel, gel-forming solution, or gel-forming suspension for fat reduction - Patents.com |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3591687A (en) * | 1968-03-13 | 1971-07-06 | George A Bray | Bile acids and derivatives thereof as anorectic agents |
| IT1137459B (en) * | 1981-04-14 | 1986-09-10 | Erregierre Spa | PRODUCTION FOR THE PREPARATION OF HIGH PURITY URSODEOXICOLIC ACID |
| JPS60130522A (en) * | 1983-12-19 | 1985-07-12 | Masatoshi Nakano | Lipid metabolic promoter for fish |
| LU88373A1 (en) * | 1993-07-12 | 1994-04-01 | Michel Urso Prof Medecin Et Ch | Weight loss product |
| US20040019027A1 (en) * | 2002-04-12 | 2004-01-29 | Barry Forman | Method of treating cerebrotendinous xanthomatosis |
-
2004
- 2004-07-20 BR BRPI0418963-9A patent/BRPI0418963A/en not_active Application Discontinuation
- 2004-07-20 WO PCT/BR2004/000123 patent/WO2006007675A1/en not_active Ceased
-
2005
- 2005-06-08 AR ARP050102333A patent/AR049210A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006007675A1 (en) | 2006-01-26 |
| BRPI0418963A (en) | 2007-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2524320T3 (en) | Composition for the prevention or treatment of disease associated with thrombus or embolus | |
| NI200800169A (en) | USE OF BENZO-FUSED HETEROCYCLIC SULFAMID DERIVATIVES FOR THE TREATMENT OF PAIN | |
| MX2020005621A (en) | FATTY ACID DERIVATIVES TO TREAT NON-ALCOHOLIC STEATOHEPATITIS. | |
| RU2009112207A (en) | SPECIFIC GLUCCORTICOSTEROID COMPOUND WITH ANTI-INFLAMMATORY ACTIVITY | |
| AR043985A1 (en) | THERAPEUTIC TREATMENT OF CONSTIPATION | |
| AR063201A1 (en) | PHARMACEUTICAL COMPOSITIONS OF ROPINIROL AND METHODS OF USE OF THE SAME | |
| AR012304A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASES AND THE USE OF SUCH COMPOSITION TO PREPARE MEDICINAL PRODUCTS TREATMENTS. | |
| BRPI0519142A2 (en) | alcohol pump foam | |
| MX2025004156A (en) | Pain-relieving topical compositions | |
| NI200800175A (en) | USE OF BENZO-FUSED HETEROCYCLIC SULFAMID DERIVATIVES FOR THE TREATMENT OF SUBSTANCE ABUSE AND ADDICTION. | |
| CL2012000446A1 (en) | Use of a topical vesicular formulation comprising one or more phospholipids and one or more surfactants in a molar ratio of 1: 1 to 25: 1 phospholipids to surfactants, for the treatment of inflammatory dermatous disorders. | |
| BRPI0804518A2 (en) | method of controlling a dog population | |
| PE20070437A1 (en) | AQUEOUS FORMULATION hFSH | |
| AR049210A1 (en) | COMPOSITION WITH TENSIOACTIVE COMPOUNDS, FOR THE REDUCTION OF FAT LOCATED IN THE HUMAN BODY AND A METHOD FOR REDUCING SUCH FAT LOCALIZED | |
| TW200602031A (en) | Antiinflammatory and pain-relieving agent for external, use | |
| BRPI0418070A (en) | personal care composition, use of a substituted urea and method for reducing color degradation of a personal care composition | |
| AR017925A1 (en) | A WATERY FORMULATION TO VERTER, TOPICALLY ACCEPTABLE, ADAPTED FOR ITS EXTERNAL APPLICATION LOCATED IN AN ANIMAL, ITS USE AND A METHOD TO FORMULATE IT | |
| PE20061077A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING 7-TERBUTOXI-IMINO-METHYL-CAMPTOTECHIN | |
| AR110250A1 (en) | TOPICAL FORMULATION INCLUDING N- [5- (AMINOSULFONIL) -4-METHYL-1,3-TIAZOL-2-IL] -N-METHYL-2- [4- (2-PYRIDINYL) -PHENYL] -ACETAMIDE | |
| AR055591A1 (en) | A SKIN PROTECTIVE TOPIC COMPOSITION AND ITS USE | |
| AR071779A1 (en) | NARCOTIC EMULSION FORMULATIONS FOR THE SURGICAL PAIN TREATMENT | |
| AR069386A1 (en) | EMULSION FORMULATIONS OF PIRAZOLONA DERIVATIVES AND KITS | |
| PE20050443A1 (en) | TRANSDERMAL PHARMACEUTICAL FORMULATIONS | |
| GT200000224A (en) | COMPOSITION FOR THE TREATMENT OF DAMAGED FABRICS. | |
| MX2022009081A (en) | CELLULAR ABSORPTION. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |